Holen Sie sich die Stockscreener-App
206.69
1.03%
-2.15
Handel nachbörslich:
207.00
0.31
+0.15%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime - Investing.com
AbbVie: A High 2026 Earnings Bar, But Shares Are Attractive On Valuation (NYSE:ABBV) - Seeking Alpha
Parkinson’s Disease Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca, Prevail Therapeutics - Barchart.com
9 Newly Overvalued Stocks this Week - Morningstar
Scotiabank Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $280 - Moomoo
How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales? - TradingView
AbbVie Lowers 2026 Earnings Guidance Amid Expenses - Intellectia AI
Sowell Financial Services LLC Has $10.85 Million Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie forecasts $744M hit from drug pipeline costs - Crain's Chicago Business
AbbVie Inc. $ABBV Shares Purchased by Kelleher Financial Advisors - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by JB Capital LLC - MarketBeat
Savvy Advisors Inc. Buys 6,646 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. (ABBV) stock price, news, quote and history - Yahoo Finance Singapore
AbbVie Inc. $ABBV is Advocate Group LLC's 4th Largest Position - MarketBeat
AbbVie's Financial Outlook Revised Amid Pipeline Progress and One-Time Charge - AD HOC NEWS
AbbVie Updates 2026 Adjusted EPS Guidance to $13.96–$14.16 Including Q1 Acquired IPR&D and Milestones Expense 1 - Minichart
AbbVie Inc. $ABBV Shares Bought by SteelPeak Wealth LLC - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Acquires 6,946 Shares of AbbVie Inc. $ABBV - MarketBeat
C2P Capital Advisory Group Trims AbbVie Stake - National Today
C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Sells 8,610 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. (ABBV) latest stock news and headlines - Yahoo Finance Australia
AbbVie reports $744 million IPR&D expense for Q1, updates 2026 earnings guidance - Investing.com
AbbVie & Amgen: Safe Dividend Stocks for Recession Fears | 2026News and Statistics - IndexBox
Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034 – DelveInsight | Visiox Pharma, TearClear, VivaVision Biotech, Abbvie, Ocuphire Pharma, Qlaris Bio, Nicox Ophthalmics, Sun Pharma - barchart.com
AbbVie Posts Record $61B Revenue as Skyrizi and Rinvoq Surge Past Peak Humira Sales - TIKR.com
Potential US Drug Tariffs Test AbbVie Margins And Growth Narrative - Yahoo Finance
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - Yahoo Finance
Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters
AbbVie Inc Stock (ABBV) Moved Down by 3.20% on Apr 2: A Full Analysis - tradingkey.com
AbbVie stock price forecast: Downside risk builds as ABBV drops 3.07% to $208 - Traders Union
AbbVie Inc. $ABBV Shares Sold by Trust Co. of Vermont - MarketBeat
Assessing AbbVie (ABBV) Valuation After New Dermatology Data And FDA Label Update - Yahoo Finance
Compagnie Lombard Odier SCmA Raises Holdings in AbbVie Inc. $ABBV - MarketBeat
Banque Pictet & Cie SA Has $88.87 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
What You Need to Know Ahead of AbbVie’s Earnings Release - Barchart.com
AbbVie Inc. stock underperforms Wednesday when compared to competitors - marketwatch.com
Thrivent Moderate Allocation Fund's AbbVie Inc(ABBV) Holding History - gurufocus.com
AbbVie Inc. $ABBV Stock Holdings Trimmed by Vaughan Nelson Investment Management L.P. - MarketBeat
Nisa Investment Advisors LLC Has $156 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Moody Lynn & Lieberson LLC Has $43.98 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Meyer Handelman Co. Boosts Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Sarcopenia Treatments Market Is Going to Boom | AbbVie • Amgen • Pfizer • Novartis - openPR.com
AbbVie Inc. $ABBV Shares Bought by Capital Advisors Inc. OK - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
AbbVie (NYSE:ABBV) Shares Up 2%Time to Buy? - MarketBeat
AbbVie Inc. stock rises Tuesday, still underperforms market - marketwatch.com
Pfizer, Bain Must Litigate Cerevel Investors’ AbbVie Deal Suit - Bloomberg Law News
ABBV Stock Quote Price and Forecast - CNN
Bernstein Maintains AbbVie(ABBV.US) With Hold Rating, Maintains Target Price $225 - 富途牛牛
AbbVie Inc Stock (ABBV) Moved Up by 3.26% on Mar 31: Drivers Behind the Movement - TradingKey
/C O R R E C T I O N -- AbbVie/ - Investing News Network
Will AbbVie's Oncology Drugs Aid Top Line in 2026? - The Globe and Mail
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting - Investing News Network
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting® - AbbVie News Center
AbbVie to Host First-Quarter 2026 Earnings Call - National Today
AbbVie to Host First-Quarter 2026 Earnings Conference Call - Moomoo
Range Financial Group LLC Has $1.08 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
J. Safra Sarasin Holding AG Reduces AbbVie Stake - National Today
J. Safra Sarasin Holding AG Sells 36,172 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Holdings Lifted by Mn Services Vermogensbeheer B.V. - MarketBeat
Financial Planning Hawaii Inc. Invests $2.90 Million in AbbVie Inc. $ABBV - MarketBeat
0.32%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):